results posted on April 6, 2022 but not sure if they are positive.
clinicaltrials.gov/ct2/hist...
clinicaltrials.gov/ct2/show...
scienceofparkinsons.com/201...
Can someone get comments from Simon from The Science of Parkinson's ?
EPI-589, PTC-589, (R)-Troloxamide quinone... - Cure Parkinson's
EPI-589, PTC-589, (R)-Troloxamide quinone Phase 2 study results 2022
1 Reply
•
Not what you're looking for?
You may also like...
AnnovisBio has initiated a 6-month Phase 3 study to evaluate 2 different doses Buntanetap (posiphen) in 450 participants with PD
AnnovisBio has initiated a 6-month, placebo-controlled, double-blind Phase 2 study to evaluate...
Ambroxol Phase 2 results
https://www.cureparkinsons.org.uk/news/ambroxol-phase-ll-results-published...
Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD
Highlights
• Oral NR increases brain NAD levels in individuals with Parkinson’s disease
• NR...
Good news related to prx002
Interesting in light of the negative results from Biogen’s study of a similar (but not the same)...
Related Posts
Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease (Exenatide-PD3)
Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS Trial
Phase 4 study to evaluate efficacy of orally administrated Trehalose in individuals with idiopathic & LRRK2-associated Parkinsons
Bilateral Pallidothalamic Tractotomy (PTT) Clinical Trials in the United States 
Anyone participating in the Buntanetap Phase 3 trial?
